ROBERT LANINGHAM: Open Payments
NPI 1700973682 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 43 payments from 8 companies in 2025. Trend: 2023 $261 · 2024 $462 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 14 | $291 |
| Amgen Inc. | 17 | $149 |
| Abbott Laboratories | 3 | $83 |
| Astellas Pharma US Inc | 3 | $83 |
| Inspire Medical Systems, Inc. | 3 | $77 |
| Indivior Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $15 |
| Echosens North America, Inc. | 1 | $11 |
Products named: Dexcom G6 Transmitter, OTEZLA, Veozah, INSPIRE, ETERNA, SUBLOCADE, PROCLAIM, VRAYLAR.
Industry payments across TX — which companies pay providers there.
